Multiple sclerosis patients with severe walking disability have clinically meaningful improvements in walking speed with prolonged-release fampridine

被引：0
|
作者：
Hartung, H. P.
Goodman, A.
Putzki, N.
机构：
来源：
JOURNAL OF NEUROLOGY | 2011年 / 258卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：260 / 261
页数：2
相关论文
共 50 条
  • [21] Effects of prolonged-release fampridine on leg muscle activity during treadmill walking in individuals with multiple sclerosis (FAMPKIN)
    Loerincz, L.
    Zoerner, B.
    Weller, D.
    Reuter, K.
    Kapitza, S.
    Farkas, M.
    Sutter, T.
    Filli, L.
    Linnebank, M.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 608 - 608
  • [22] Efficacy and safety of fampridine for walking disability in multiple sclerosis
    Arpin, Eva Costa
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2020, 10 (05) : 277 - 287
  • [23] Recommendations for the Use of Prolonged-Release Fampridine in Patients with Multiple Sclerosis (MS)
    Preiningerova, Jana Lizrova
    Baumhackl, Ulf
    Csepany, Tunde
    Czaplinski, Adam
    Deisenhammer, Florian
    Derfuss, Tobias
    Fabjan, Tanja H.
    Fazekas, Franz
    Fuchs, Siegrid
    Havrdova, Eva
    Ledinek, Alenka Horvath
    Illes, Zsolt
    Jazbec, Sasa Sega
    Klimova, Eleonora
    Komoly, Samuel
    Kurca, Egon
    Linnebank, Michael
    Lisy, Lubomir
    Mares, Jan
    Prochazkova, Lubica
    Csilla, Rozsa
    Szilasiova, Jarmila
    Stourac, Pavel
    Talab, Radomir
    Turcani, Peter
    Vachova, Marta
    Vecsei, Laszlo
    Vodusek, David
    Zapletalova, Olga
    Berger, Thomas
    CNS NEUROSCIENCE & THERAPEUTICS, 2013, 19 (05) : 302 - 306
  • [24] Effects of prolonged-release fampridine on postural control in patients with multiple sclerosis
    Reuter, K.
    Koeszeghi, L.
    Weller, D.
    Sutter, T.
    Kapitza, S.
    Farkas, M.
    Filli, L.
    Linnebank, M.
    Zoerner, B.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 521 - 521
  • [25] Prolonged-release fampridine treatment and walking ability and balance in patients with multiple sclerosis: results of the randomized, double-blind MOBILE study
    Mehta, L. R.
    Lycke, J.
    Short, C.
    Gasperini, C.
    Hupperts, R.
    McNeill, M.
    Medori, R.
    Elkins, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 192 - 192
  • [26] Prolonged-Release Fampridine Treatment and Walking Ability and Balance in Patients with Multiple Sclerosis: Results of the Randomized, Double-Blind MOBILE Study
    Lycke, Jan
    Short, Christine
    Gasperini, Claudio
    Hupperts, Raymond
    McNeil, Manjit
    Medori, Rossella
    Mehta, Lahar
    Elkins, Jacob
    NEUROLOGY, 2014, 83 (02) : E36 - E36
  • [27] Prolonged-release fampridine treatment and walking ability and balance in patients with multiple sclerosis: results of the randomized, double-blind MOBILE study
    Mehta, L. R.
    Lycke, J.
    Short, C.
    Gasperini, C.
    Hupperts, R.
    McNeill, M.
    Medori, R.
    Elkins, J.
    JOURNAL OF NEUROLOGY, 2014, 261 : S134 - S134
  • [28] The effect of fampridine on walking speed in people with multiple sclerosis
    Spoljar, Ana
    Pertot, Anja Udovcic
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (07) : 1035 - 1035
  • [29] Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial
    Hupperts, Raymond
    Lycke, Jan
    Short, Christine
    Gasperini, Claudio
    McNeill, Manjit
    Medori, Rossella
    Tofil-Kaluza, Agata
    Hovenden, Maria
    Mehta, Lahar R.
    Elkins, Jacob
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (02) : 212 - 221
  • [30] Responses to items of the MSWS-12 differ depending on EDSS and the impact of prolonged-release fampridine on walking speed
    McGuigan, C.
    Schapiro, R.
    Putzki, N.
    Hobart, J.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S473 - S474
12345